Fresenius Kabi Oncology Ltd. | FKONCO | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2012 | 2013 | |
---|---|---|---|
Cash and cash equiva... |
| 136 | 5 |
Short-term investment |
| 0 | 0 |
Accounts receivables |
| 2,017 | 1,851 |
Inventories |
| 1,886 | 2,451 |
Deferred income taxes |
| 0 | 0 |
Other current assets |
| 1,248 | 795 |
Total current assets |
| 5,287 | 5,102 |
Gross property plant... |
| 2,995 | 3,472 |
Accumulated Depriciat... |
| 0 | 0 |
Net property, plant and Eq... |
| 2,995 | 3,472 |
Work in Progress |
| 1,338 | 1,586 |
Miscellaneous Investment |
| 0.3 | 0.3 |
Deferred income taxes |
| 0 | 0 |
Intangible assets |
| 98 | 89 |
Goodwill |
| 0 | 0 |
Other long-term assets |
| 383 | 138 |
Total non-current assets |
| 4,815 | 5,286 |
Total assets |
| 10,101 | 10,388 |
Short-term debt |
| 521 | 449 |
Accounts Payable... |
| 1,394 | 914 |
Provisions |
| 771 | 717 |
Taxes Payable |
| 0 | 0 |
Deferred Revenues |
| 0 | 0 |
Capital Leases |
| 0 | 0 |
Other current liabilities |
| 62 | 305 |
Total current liabilities |
| 2,748 | 2,385 |
Long-term debt |
| 952 | 952 |
Investments Liabilities |
| 0 | 0 |
Deferred tax liabilities |
| 147 | 244 |
Provisions |
| 329 | 75 |
Capital Leases |
| 0 | 0 |
Other longterm liabilities |
| 0 | 0 |
Total non-current liabilities |
| 1,428 | 1,271 |
Total liabilities |
| 4,175 | 3,656 |
Share Capital |
| 158 | 158 |
Share premium |
| 768 | 0 |
Retained earnings |
| 5,000 | 6,574 |
Accumulated other equity |
| 0 | 0 |
Preferred Stock |
| 0 | 0 |
Minority Interest |
| 0 | 0 |
Total Equity |
| 5,926 | 6,732 |
Total Liabilities and Equity |
| 10,101 | 10,388 |
Cash per Share |
| Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade |